skip to primary navigationskip to content
 

Spectral Edge showcase their Eyeteq and Nighteq technology at the OTTtv World Summit

last modified Nov 17, 2016 05:08 PM
ideaSpace West members, Spectral Edge, have been receiving a lot of media attention recently after showcasing their image processing technology at the OTTtv World Summit on the 8th to 10th November, 2016 in London.

Spectral Edge’s Managing Director, Christopher Cytera, was interviewed at the event and discusses how the company’s video personalisation technology enhances the viewing experience for certain kinds of viewer, particularly the 4.5% of the population that experience colour blindness (source: www.colourblindawareness.org).  

Eyeteq

Spectral Edge’s technology for improving colour visibility in images is known as ‘Eyeteq’. Eyeteq uses a patented algorithm to reconstruct each image frame, concentrating the spectral energy into wavelengths to which someone with colour blindness is more sensitive. In doing so, this allows the viewer to differentiate colours that otherwise could not be seen. The visual enhancement is shown very clearly with the following video.

 

Nighteq

Using the same algorithms as Eyeteq, Spectral Edge have also created a product known as Nighteq. Studies have shown that overexposure to blue light in the evenings can reduce sleepiness and contribute to sleep deprivation by suppressing melatonin production. Nighteq slowly reduces the amount of blue light emitted by an image, and in turn increases the amount of red light, matching our bodies natural circadian rhythms. The application could be of particular interest to parents in readying their children for bed. The technology is explained in the following video.

 

About the OTTtv World Summit 2016 event

The OTTtv World Summit looks at OTT video services and the future of TV delivery. Find out more information here.

RSS Feed Latest news

Spotlight on Mursla

Feb 03, 2019

Cancer is one of the most challenging global issues an entrepreneur could choose to tackle. But Pierre Arsène and Victor Serdio are doing just that with their company Mursla. Based at ideaSpace West, Mursla is developing a breakthrough technology for early cancer detection using liquid biopsies, offering a less invasive and more responsive approach to diagnosis, treatment and cure. To mark World Cancer Day on the 4th February, we asked Pierre to explain more about Mursla and the bold ideas and enthusiasm driving this bright company.

LESSONS FROM A FOUNDER: What's Your 2019 Startup Goal?

Jan 30, 2019

For many of us, a new year often starts with an optimistic resolution to change – join the gym, write a book, travel perhaps. But if you’re running a startup, January is a great time to assess your company’s development and set fresh goals for the coming year. We asked four founders at ideaSpace to reflect on progress and share their area of focus for 2019.

GeoSpock Lands £10 Million in Additional Funding 

Jan 09, 2019

ideaSpace alumni and extreme data specialists, GeoSpock, have secured an extra  £10 million in funding. The latest round was led by Cambridge Innovation Capital (CIC) jointly with Parkwalk Advisors and Japanese firms Global Brain and 31Ventures. Japanese data tech company KDDI Supership joined as a strategic investor. Investment was also secured from existing investor, Jonathan Milner.

A Breath Test Could Detect Early Cancer Signs

Jan 06, 2019

CRUK and ideaSpace City members, Owlstone Medical, have launched a new trial to discover whether it's possible to detect early stage cancer symptoms from a person's breath.

Petagene secure $2.1 Million in Funding 

Jan 03, 2019

2019 is off to a great start for the Petagene team who have been awarded $2.1 million in additional funding. The latest round was lead by U.S. venture firm Romulus Capital, with collaboration from other unnamed investors in London and Silicon Valley, bringing the total funding awarded to $3.2 million.

View all news